CULTIVARIUM · RADIO
← On air
Beyond the Bench

RNA Tagging Enzyme Controls Cell Division Transcription

Beyond the Bench · with Sofia & Daniel · Recorded Aug 29, 2026
More episodes → Share on X Read the paper →
Transcript

[SOFIA] Okay, so Daniel, you know how when a cell divides, it basically hits pause on almost everything else to focus on that one job?

[DANIEL] Yes, the cell cycle is a masterclass in coordinated molecular events. It's an energy-intensive process, so prioritizing resources makes sense.

[SOFIA] Exactly! And one of the biggest things it pauses is making new RNA – transcription basically grinds to a halt. We've known for a while that this shutdown happens, and it's pretty extreme. But exactly *how* the cell flips that "off" switch has been a bit of a mystery, with a lot of pieces still missing.

[DANIEL] That’s right. Transcription is fundamental. A global shutdown during M-phase, the mitosis phase, is a dramatic event. We understand some of the players involved, like chromatin condensation, which physically makes DNA less accessible, but a complete picture of the regulatory cascade has been elusive.

[SOFIA] Well, get this: A new study, out of Yale, has found a totally unexpected player in this whole transcription shutdown story. They've identified an enzyme that's usually known for tagging RNA molecules, but it turns out to be directly wired into the cell division machinery itself, acting as a crucial part of this "off" switch.

[DANIEL] An enzyme primarily known for RNA modification now implicated in cell cycle regulation of transcription? That’s certainly an interesting intersection of pathways. What exactly is this enzyme, and what role is it playing?

[SOFIA] It's an enzyme called METTL3. Now, METTL3 is most famous for putting a specific chemical tag, an N6-methyladenosine, or m6A, on RNA molecules. It's a really important modification for RNA stability and translation. But here's the twist: the researchers found that during cell division, METTL3 itself gets phosphorylated.

[DANIEL] Phosphorylation can be a critical regulatory switch for protein activity and localization. So, METTL3's typical RNA-tagging function is modulated, or is it taking on an entirely new role when phosphorylated during mitosis?

[SOFIA] That's the cool part! When METTL3 gets phosphorylated in M-phase, it doesn't just stop tagging RNA, it actually moves. It relocates from its usual spot in the nucleus to the condensed chromosomes and directly interacts with an enzyme called CDK1. CDK1 is a key cyclin-dependent kinase that drives cells into mitosis. This interaction between phosphorylated METTL3 and CDK1 then leads to the deactivation of RNA polymerase II – which is the enzyme responsible for transcribing most genes. It's like a direct line from the cell division master regulator to the transcription machinery.

[DANIEL] So, a known RNA modification enzyme is essentially repurposed as a structural or regulatory component in the mitotic transcription repression pathway through phosphorylation and protein-protein interaction. That’s a sophisticated mechanism. What was the evidence for this interaction and subsequent RNA polymerase II deactivation? Were they able to disrupt this interaction and see if it rescued transcription during mitosis?

[SOFIA] They showed that this interaction is crucial. When they mutated the phosphorylation sites on METTL3, preventing it from being phosphorylated, or disrupted its ability to bind to CDK1, the cell couldn't fully shut down transcription during mitosis. RNA polymerase II stayed active when it shouldn't have been. It really points to METTL3 being a central, previously overlooked, part of this shutdown mechanism. And because this pathway is so fundamental, understanding it better could open up new avenues for targeting cancer cells, which rely on uncontrolled division.

[DANIEL] The idea of targeting a cell cycle-dependent regulatory node like this, especially one that's a repurposing of a known RNA-modifying enzyme, is intriguing. It adds a layer of complexity to our understanding of gene regulation during cell division and certainly warrants further investigation into its therapeutic potential.